1. Home
  2. CORT vs KBR Comparison

CORT vs KBR Comparison

Compare CORT & KBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • KBR
  • Stock Information
  • Founded
  • CORT 1998
  • KBR 1901
  • Country
  • CORT United States
  • KBR United States
  • Employees
  • CORT N/A
  • KBR N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • KBR Military/Government/Technical
  • Sector
  • CORT Health Care
  • KBR Industrials
  • Exchange
  • CORT Nasdaq
  • KBR Nasdaq
  • Market Cap
  • CORT 7.5B
  • KBR 6.3B
  • IPO Year
  • CORT N/A
  • KBR 2006
  • Fundamental
  • Price
  • CORT $72.98
  • KBR $47.62
  • Analyst Decision
  • CORT Strong Buy
  • KBR Buy
  • Analyst Count
  • CORT 4
  • KBR 7
  • Target Price
  • CORT $142.00
  • KBR $64.33
  • AVG Volume (30 Days)
  • CORT 1.6M
  • KBR 1.5M
  • Earning Date
  • CORT 07-28-2025
  • KBR 07-31-2025
  • Dividend Yield
  • CORT N/A
  • KBR 1.39%
  • EPS Growth
  • CORT 8.36
  • KBR N/A
  • EPS
  • CORT 1.14
  • KBR 2.98
  • Revenue
  • CORT $685,446,000.00
  • KBR $7,979,000,000.00
  • Revenue This Year
  • CORT $35.83
  • KBR $14.27
  • Revenue Next Year
  • CORT $35.24
  • KBR $8.57
  • P/E Ratio
  • CORT $63.26
  • KBR $15.99
  • Revenue Growth
  • CORT 30.93
  • KBR 12.84
  • 52 Week Low
  • CORT $29.42
  • KBR $43.89
  • 52 Week High
  • CORT $117.33
  • KBR $72.60
  • Technical
  • Relative Strength Index (RSI)
  • CORT 49.68
  • KBR 33.92
  • Support Level
  • CORT $68.52
  • KBR $46.54
  • Resistance Level
  • CORT $75.95
  • KBR $48.62
  • Average True Range (ATR)
  • CORT 2.66
  • KBR 1.26
  • MACD
  • CORT -0.13
  • KBR -0.30
  • Stochastic Oscillator
  • CORT 42.13
  • KBR 13.78

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About KBR KBR Inc.

KBR, formerly Kellogg Brown & Root, is global provider of technology, integrated engineering, procurement, and construction delivery, and operations and maintenance services. The company's business is organized into two segments: government solutions and sustainable technology solutions. KBR has operations in over 30 countries and employs approximately 34,000 people. The firm generated $7.7 billion in revenue in 2024.

Share on Social Networks: